A novel rearrangement of occludin causes brain calcification and renal dysfunction |
| |
Authors: | Marissa A. LeBlanc Lynette S. Penney Daniel Gaston Yuhao Shi Erika Aberg Mathew Nightingale Haiyan Jiang Roxanne M. Gillett Somayyeh Fahiminiya Christine Macgillivray Ellen P. Wood Philip D. Acott M. Naeem Khan Mark E. Samuels Jacek Majewski Andrew Orr Christopher R. McMaster Karen Bedard |
| |
Affiliation: | 1. Department of Pathology, Dalhousie University, 5850 College St., Sir Charles Tupper Medical Building, Room 11-F, Halifax, NS, Canada 2. Department of Pediatrics, Dalhousie University, Halifax, NS, Canada 3. Department of Human Genetics, McGill University, Montreal, QC, Canada 4. Maritime Medical Genetics, IWK Health Centre, Halifax, NS, Canada 5. Department of Biostatistics, Princess Margaret Centre, Toronto, ON, Canada 6. Department of Ophthalmology, Capital Health, Halifax, NS, Canada 7. Department of Radiology, Dalhousie University, Halifax, NS, Canada 8. Department of Medicine, University of Montreal, Montreal, QC, Canada 9. Department of Ophthalmology, Dalhousie University, Halifax, NS, Canada 10. Department of Pharmacology, Dalhousie University, Halifax, NS, Canada
|
| |
Abstract: | Pediatric intracranial calcification may be caused by inherited or acquired factors. We describe the identification of a novel rearrangement in which a downstream pseudogene translocates into exon 9 of OCLN, resulting in band-like brain calcification and advanced chronic kidney disease in early childhood. SNP genotyping and read-depth variation from whole exome sequencing initially pointed to a mutation in the OCLN gene. The high degree of identity between OCLN and two pseudogenes required a combination of multiplex ligation-dependent probe amplification, PCR, and Sanger sequencing to identify the genomic rearrangement that was the underlying genetic cause of the disease. Mutations in exon 3, or at the 5–6 intron splice site, of OCLN have been reported to cause brain calcification and polymicrogyria with no evidence of extra-cranial phenotypes. Of the OCLN splice variants described, all make use of exon 9, while OCLN variants that use exons 3, 5, and 6 are tissue specific. The genetic rearrangement we identified in exon 9 provides a plausible explanation for the expanded clinical phenotype observed in our individuals. Furthermore, the lack of polymicrogyria associated with the rearrangement of OCLN in our patients extends the range of cranial defects that can be observed due to OCLN mutations. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|